Suboptimal dosing, no checkpoint inhibitor, double
Post# of 154510
(Total Views: 283)
Posted On: 06/25/2025 8:48:49 PM
Suboptimal dosing, no checkpoint inhibitor, double survival, and more. Plus one survivor with no signs of disease. This is remarkable.
This may not yet overwhelm the markets, but it is another big indication of the power of the miracle molecule. With proper dosing, checking on PD-L1 and the addition of a checkpoint inhibitor, I believe we'll have a winning hand with many more to come.
Go long and stay long
This may not yet overwhelm the markets, but it is another big indication of the power of the miracle molecule. With proper dosing, checking on PD-L1 and the addition of a checkpoint inhibitor, I believe we'll have a winning hand with many more to come.
Go long and stay long
(10)
(0)